Literature DB >> 10585274

Monocytically differentiating HL60 cells proliferate rapidly before they mature.

G Brown1, M A Choudhry, J Durham, M T Drayson, R H Michell.   

Abstract

1alpha,25-Dihydroxyvitamin D(3) (D(3)) provokes growth arrest and monocytic differentiation in myeloid cells. Although it is usually assumed that the cellular events leading to growth arrest start within one cell cycle of D(3) addition, there is also evidence that D(3) provokes the expression of proliferation-related genes and accelerates cell division. Herein we clarify the relationship between proliferation and maturation in differentiating HL60 cells. Cells were cultured singly, D(3) was added at various stages of the cell cycle, the progeny were counted, and the proportions of mature monocytes were determined. Initially, the D(3)-treated cells proliferated at an accelerated rate, and they matured only later. If cells encountered D(3) early in G1 they divided two to four times before maturing, and if they encountered D(3) later in the cell cycle they underwent an extra division. Indomethacin slows HL60 cell multiplication by prolonging G1, and when these slower-growing cells were exposed to D(3), they matured after the usual period but underwent one division less than indomethacin-free cells. Contrary to common assumptions, we conclude that promyeloid cells do not initiate growth arrest or monocytic maturation immediately after exposure to D(3). Instead, an encounter with D(3) early in G1 sets in train a complex differentiation program. This consists of 2-3 days of rapid proliferation-probably employing cell cycles with a shortened G1 phase-that is followed by growth arrest and maturation. As a result, a single D(3)-treated promyeloid cell gives rise to 10 or more mature monocytes. These observations not only explain why "differentiating" cells express proliferation-related characteristics soon after D(3) addition, but they also show that the process of D(3)-induced monocytic differentiation is much more complex than has previously been realized. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585274     DOI: 10.1006/excr.1999.4660

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Regulation of Id gene expression by type I insulin-like growth factor: roles of Stat3 and the tyrosine 950 residue of the receptor.

Authors:  M Prisco; F Peruzzi; B Belletti; R Baserga
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 2.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

Review 3.  IGF-I receptor signalling in transformation and differentiation.

Authors:  B Valentinis; R Baserga
Journal:  Mol Pathol       Date:  2001-06

4.  Polypyrimidine tract-binding protein enhances the internal ribosomal entry site-dependent translation of p27Kip1 mRNA and modulates transition from G1 to S phase.

Authors:  Sungchan Cho; Jong Heon Kim; Sung Hoon Back; Sung Key Jang
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

5.  Complex changes in cellular inositol phosphate complement accompany transit through the cell cycle.

Authors:  Christopher J Barker; Joanne Wright; Philip J Hughes; Christopher J Kirk; Robert H Michell
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

Review 6.  Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.

Authors:  Philip J Hughes; Ewa Marcinkowska; Elzbieta Gocek; George P Studzinski; Geoffrey Brown
Journal:  Leuk Res       Date:  2009-10-06       Impact factor: 3.156

7.  The LINC-less granulocyte nucleus.

Authors:  Ada L Olins; Thanh V Hoang; Monika Zwerger; Harald Herrmann; Hanswalter Zentgraf; Angelika A Noegel; Iakowos Karakesisoglou; Didier Hodzic; Donald E Olins
Journal:  Eur J Cell Biol       Date:  2008-11-18       Impact factor: 4.492

Review 8.  Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs.

Authors:  Aleksandra Marchwicka; Małgorzata Cebrat; Preetha Sampath; Lukasz Snieżewski; Ewa Marcinkowska
Journal:  Front Oncol       Date:  2014-05-27       Impact factor: 6.244

9.  Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML).

Authors:  Naomi Galili; Emmanuelle Devemy; Azra Raza
Journal:  J Hematol Oncol       Date:  2008-07-10       Impact factor: 17.388

Review 10.  The Use of 1α,25-Dihydroxyvitamin D₃ as an Anticancer Agent.

Authors:  Ewa Marcinkowska; Graham R Wallace; Geoffrey Brown
Journal:  Int J Mol Sci       Date:  2016-05-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.